Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Caelyx Pegylated Liposomal 2mg/ml (25ml presentation) - EU/1/96/011/003-004
- Cernevit, Powder for Solution for Injection or Infusion - PA2299/019/001
- Fucidin H 20mg/g + 10mg/g Cream - PA0046/005/005
- Lercanidipine Clonmel 10mg Tablets - PA0126/187/001
- Nortem 20mg Tablets - PA1986/085/002
- Ondansetron 2mg/ml Solution for Injection or Infusion (4ml) - PA0577/083/001
- Phenergan 25mg Film Coated Tablets - PA23180/011/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Dynastat 40mg Powder for Solution for Injection - EU/1/02/209/005
- Epivir 10mg/ml Oral Solution - EU/1/96/015/002
- Gemcitabine Actavis 40mg/ml Concentrate for Solution for Infusion (5ml vial) - PA1380/182/001
- Lyrica 200mg Hard Capsules - EU/1/04/279/021
- Palexia 75mg Film Coated Tablets - PA2242/012/002
- Palexia 100mg Film Coated Tablets - PA2242/012/003
- Paracetamol 500mg Tablets - PA2315/065/003
- Pregabalin Krka 75mg Capsules - PA1347/050/003
- Rivotril 0.5mg Tablets - PA2239/020/001
- Tipol 125mg Suppository - PA0126/331/002
- Warfant 5mg Tablets - PA0073/139/003
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.